Department of General Surgery, Cleveland Clinic Foundation, 18101 Lorain Avenue, Cleveland, OH, 44111, USA.
Department of Surgical Oncology, Edward-Elmhurst Health, Elmhurst, IL, USA.
Surg Endosc. 2024 Oct;38(10):5678-5685. doi: 10.1007/s00464-024-11147-5. Epub 2024 Aug 12.
The frequency of minimally invasive distal pancreatectomy is gradually exceeding that of the open approach. Our study aims to compare short-term outcomes of robotic (RDP) and laparoscopic (LDP) distal pancreatectomies for pancreatic ductal adenocarcinoma (PDAC) using a national database.
The National Cancer Database was utilized to identify patients with PDAC who underwent distal pancreatectomy from 2010-2020. Short-term technical and oncologic outcomes such as margin status and nodal harvest were included. Propensity-score matching (PSM) was performed comparing LDP and RDP cohorts. Multivariate logistic-regression models were then used to assess the impact of institutional volume on the MIDP surgical and technical oncologic outcomes.
1537 patients underwent MIDP with curative intent. Most cases were laparoscopic (74.4%, n = 1144), with a gradual increase in robotic utilization, from 8.7% in 2010 to 32.0% of MIDP cases ten years later. For PSM, 698 LDP patients were matched with 349 RDP. The odds of conversion to an open case were 58% less in RDP (12.6%) compared to LDP (25.5%) with no statistically significant difference in technical oncologic results. There was no difference in length of stay (OR = 1.0[0.7-1.4]), 30-day mortality (OR = 0.5[0.2-2.0]) or 90-day mortality (OR = 1.1[0.5-2.4]) between RDP and LDP, although there was a higher 30-day readmission rate with RDP (OR = 1.71[1.1-2.7]). There were statistically significant differences in technical oncologic outcomes (nodal harvest, margin status, initiation of adjuvant therapy) based on MIDP volume quartiles.
Laparoscopic and robotic distal pancreatectomy have similar peri- and post-operative surgical and oncologic outcomes, with a higher rate of conversion to open in the laparoscopic cohort.
微创远端胰腺切除术的频率逐渐超过开放手术。本研究旨在使用国家数据库比较机器人(RDP)和腹腔镜(LDP)远端胰腺切除术治疗胰腺导管腺癌(PDAC)的短期结果。
利用国家癌症数据库,从 2010 年至 2020 年,确定接受远端胰腺切除术的 PDAC 患者。包括短期技术和肿瘤学结果,如边缘状态和淋巴结采集。对 LDP 和 RDP 队列进行倾向评分匹配(PSM)。然后使用多变量逻辑回归模型评估机构容量对 MIDP 手术和技术肿瘤学结果的影响。
1537 例患者接受了有治愈意图的 MIDP。大多数病例为腹腔镜(74.4%,n=1144),机器人使用率逐渐增加,从 2010 年的 8.7%增加到十年后 MIDP 病例的 32.0%。对于 PSM,将 698 例 LDP 患者与 349 例 RDP 患者进行匹配。与 LDP(25.5%)相比,RDP 中转开腹手术的可能性降低了 58%(12.6%),但在技术肿瘤学结果方面无统计学差异。两组患者在住院时间(OR=1.0[0.7-1.4])、30 天死亡率(OR=0.5[0.2-2.0])或 90 天死亡率(OR=1.1[0.5-2.4])方面无差异,尽管 RDP 患者的 30 天再入院率较高(OR=1.71[1.1-2.7])。根据 MIDP 体积四分位数,在技术肿瘤学结果(淋巴结采集、边缘状态、辅助治疗的启动)方面存在统计学差异。
腹腔镜和机器人远端胰腺切除术具有相似的围手术期和术后手术和肿瘤学结果,腹腔镜组中转开腹的比例更高。